Targeted mutation detection in breast cancer using MammaSeq™ NG Smith, R Gyanchandani, OS Shah, GT Gurda, PC Lucas, ... Breast Cancer Research 21, 1-11, 2019 | 31 | 2019 |
ATLANTIS-attractor landscape analysis toolbox for cell fate discovery and reprogramming OS Shah, MFA Chaudhary, HA Awan, F Fatima, Z Arshad, B Amina, ... Scientific Reports 8 (1), 3554, 2018 | 19 | 2018 |
Outcomes after sentinel lymph node biopsy and radiotherapy in older women with early-stage, estrogen receptor–positive breast cancer N Carleton, J Zou, Y Fang, SE Koscumb, OS Shah, F Chen, S Beriwal, ... JAMA network open 4 (4), e216322-e216322, 2021 | 17 | 2021 |
Mixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinoma A Nasrazadani, Y Li, Y Fang, O Shah, JM Atkinson, JS Lee, PF McAuliffe, ... British journal of cancer 128 (6), 1030-1039, 2023 | 8 | 2023 |
A Personalized Therapeutics Approach Using an In Silico Drosophila Patient Model Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal … MN Gondal, RN Butt, OS Shah, MU Sultan, G Mustafa, Z Nasir, R Hussain, ... Frontiers in Oncology 11, 692592, 2021 | 7 | 2021 |
Identifying genomic alterations in patients with stage IV breast cancer using MammaSeq: an international collaborative study OS Shah, A Soran, M Sahin, BA Knapick, S Ugras, E Celik, PC Lucas, ... Clinical Breast Cancer 21 (3), 210-217, 2021 | 7 | 2021 |
TISON: a next-generation multi-scale modeling theatre for in silico systems oncology MN Gondal, MU Sultan, A Arif, A Rehman, HA Awan, Z Arshad, W Ahmed, ... BioRxiv, 2021.05. 04.442539, 2021 | 5 | 2021 |
In silico Drosophila Patient Model Reveals Optimal Combinatorial Therapies for Colorectal Cancer MN Gondal, RN Butt, OS Shah, Z Nasir, R Hussain, H Khawar, M Tariq, ... bioRxiv, 2020.08. 31.274829, 2020 | 2 | 2020 |
Systems approach for congruence and selection of cancer models towards precision medicine J Zou, O Shah, YC Chiu, T Ma, JM Atkinson, S Oesterreich, AV Lee, ... PLOS Computational Biology 20 (1), e1011754, 2024 | 1 | 2024 |
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations OS Shah, A Nasrazadani, J Foldi, JM Atkinson, CG Kleer, PF McAuliffe, ... bioRxiv, 2023.09. 09.557013, 2023 | 1 | 2023 |
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line model A Elangovan, EA Bossart, A Basudan, N Tasdemir, OS Shah, K Ding, ... bioRxiv, 2023.09. 15.558023, 2023 | 1 | 2023 |
Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer K Ding, L Chen, KM Levine, MJ Sikora, N Tasdemir, D Dabbs, ... bioRxiv, 2024.03. 18.585626, 2024 | | 2024 |
Multi-omic profiling of E-cadherin deficient breast cancers and their in-vitro models towards enabling precision medicine OS Shah University of Pittsburgh, 2023 | | 2023 |
Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic … OS Shah, F Chen, A Wedn, A Kashiparekh, B Knapick, J Chen, ... bioRxiv, 2023.09. 26.559548, 2023 | | 2023 |
The invasive lobular cancer cell line encyclopedia (ICLE) for studying potential biomarkers and exploring therapeutic opportunities. OS Shah, F Chen, A Webn, A Kashiparekh, L Savariau, B Clifford, ... Biorxiv: the Preprint Server for Biology, 2023 | | 2023 |
Abstract PD4-07: PD4-07 Uncovering molecular heterogeneity of mixed ductal and lobular carcinoma using digital spatial profiling OS Shah, A Nasrazadani, JM Atkinson, C Kleer, PF McAuliffe, R Bhargava, ... Cancer Research 83 (5_Supplement), PD4-07-PD4-07, 2023 | | 2023 |
A Personalized Therapeutics Approach Using an In Silico MN Gondal, RN Butt, OS Shah, MU Sultan, G Mustafa, Z Nasir, R Hussain, ... Combinatorial Approaches for Cancer Treatment: from Basic to Translational …, 2022 | | 2022 |
Abstract P5-12-03: Wcrc-25: A novel luminal invasive lobular carcinoma cell line model A Elangovan, EA Bossart, A Basudan, N Tasdemir, OS Shah, K Ding, ... Cancer Research 82 (4_Supplement), P5-12-03-P5-12-03, 2022 | | 2022 |
Abstract PS19-06: Role of the calcium-sensing receptor (CaSR) in invasive lobular breast carcinoma metastasis to the ovary Y Qin, L Savariau, AM Basudan, O Shah, Z Li, T Liu, N Tasdemir, ... Cancer Research 81 (4_Supplement), PS19-06-PS19-06, 2021 | | 2021 |
Abstract PS7-15: Mixed invasive ductal lobular carcinomas (mDLC) are clinically more similar to invasive lobular carcinoma (ILC) than to invasive ductal carcinoma (IDC) A Nasrazadani, Y Li, Y Fang, O Shah, JM Atkinson, JS Lee, PF McAuliffe, ... Cancer Research 81 (4_Supplement), PS7-15-PS7-15, 2021 | | 2021 |